EUVIMEDEUVIMED entdecken
Crossref

Recent Advancement in Protein and Polysaccharides Based Bioinks for Harnessing the Potential of 3D Bioprinting in Diverse Biomedical Applications

Mosina, Swati Kumari, Pradakshina Sharma, Mohd. Rahil Hasan, Shariq Suleman, Nitesh Malhotra, Jagriti Narang

Regenerative Engineering and Translational Medicine · 29.10.2026

DOI: 10.1007/s40883-026-00636-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regenerative Engineering and Translational Medicine, online erschienen am 29.10.2026. Verfasst von Mosina und 6 weiteren Autor:innen. Die Arbeit nennt 184 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 3D bioprinting technology is used to fabricate living cells and structures which closely mimic the humanised body cells-the various bioprinting methods, such as Inkjet, laser-assisted printing, microfluidics and so on. For printing, bioinks are required, which include living cells and biomaterials composed of proteins and polysaccharides. The technique is used for transplantation and regenerative therapies, but also for drug testing and personalised medicine. This technique also overcomes current challenges, such as ensuring sufficient blood vessel growth during the printing process. The 3d bioprinting technique is advanced and rapid, which has innovated in printing living cells, methods, materials and device technologies. As researchers continue to advance 3D bioprinting technology, the future of healthcare provides significant benefits to resolving fundamental biological and engineering issues by fabricating biological tissues according to individual requirements, which improves the patient outcome by ensuring long-term functionality and also minimises the use of laboratory animals for research experiments. Abstract 3D bioprinting has rapidly expanded the opportunities for fabricating simple, complex, structurally similar biological structures that mimic native tissues. Combined with biomaterials compatible with living cells, the working principle of additive manufacturing in 3D bioprinting is identical, as it closely follows natural tissue architecture, thus showing a significant improvement over traditional methods like regeneration. These treatments can potentially heal multiple tissues, including vascular, dental pulp formation, tooth regeneration, bone healing, neural nerve tract repair, spinal cord tissue reconstitution, and external ear reconstruction/corneal replacement. Aside from its obvious applications as a tissue regeneration tool, 3D bioprinting is widely used in other biomedical research areas, such as drug discovery, which forms advanced local drug delivery systems that can target tissues or cells specifically. The historical developmental timeline in which current bioprinting technologies emerged started with stereolithography and concluded with summarising inkjet, extrusion, laser-assisted printing, microfluidic technology, the HITS-Bio platform, and the Kenzan bioprinting method. A fundamental component of successful bioprinting is the formulation of bioinks, which are hydrogels comprised of biological macromolecules, including proteins (like collagen, gelatin, etc.) and polysaccharides (like alginate, hyaluronic acid, etc.), that include living cells suspended in them. This review also provides valuable insights into critical hurdles that must be overcome to advance the field, such as vascularisation and viable cell survival in thick tissue constructs, and elaborates novel strategies for improving bio-ink formulations or printability. It also highlights the global 3D bioprinting industry and how 3D bioprinting could resolve the restrictions of conventional tissue transplantation. This extensive comprehension aims to provide a high-level overview of the rapidly maturing capabilities in 3D bioprinting for tissue engineering and how they are revolutionising regenerative medicine. Graphical Abstract

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Mosina, Kumari, S., Sharma, P., Hasan, M. R., Suleman, S., Malhotra, N., & Narang, J. (2026). Recent Advancement in Protein and Polysaccharides Based Bioinks for Harnessing the Potential of 3D Bioprinting in Diverse Biomedical Applications. Regenerative Engineering and Translational Medicine. https://doi.org/10.1007/s40883-026-00636-9

Vancouver

Mosina, Kumari S, Sharma P, Hasan MR, Suleman S, Malhotra N, et al. Recent Advancement in Protein and Polysaccharides Based Bioinks for Harnessing the Potential of 3D Bioprinting in Diverse Biomedical Applications. Regenerative Engineering and Translational Medicine. 2026. doi:10.1007/s40883-026-00636-9

BibTeX
@article{Mosina2026,
  author = {Mosina and Kumari, Swati and Sharma, Pradakshina and Hasan, Mohd. Rahil and Suleman, Shariq and Malhotra, Nitesh and Narang, Jagriti},
  title = {Recent Advancement in Protein and Polysaccharides Based Bioinks for Harnessing the Potential of 3D Bioprinting in Diverse Biomedical Applications},
  journal = {Regenerative Engineering and Translational Medicine},
  year = {2026},
  doi = {10.1007/s40883-026-00636-9}
}
Kostenlos starten →